Original Data
Rev Diabet Stud,
2010,
7(2):168-182 |
DOI 10.1900/RDS.2010.7.168 |
Human Placenta-Derived Mesenchymal Stem Cells and Islet-Like Cell Clusters Generated From These Cells as a Novel Source for Stem Cell Therapy in Diabetes
Sachin Kadam1, Sudhakar Muthyala2, Prabha Nair2, Ramesh Bhonde3
1National Center for Cell Science, Ganeshkhind, Pune 411007, MS, India
2Division of Tissue Engineering and Regeneration Technologies, BMT Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Poojappura, Thiruvananthapuram 695012, Kerala, India
3Stempeutics Research Malaysia SDN BHD ,Technology Park Malaysia, Bukit Jalil, 57000 Kuala Lumpur, Malaysia
Address correspondence to: Ramesh Bhonde, e-mail: rrbhonde@gmail.com
Keywords: human placenta-derived stem cell, diabetes, mesenchymal stem cell, transplant, beta-cell, islet, differentiation, macrocapsule, immunoisolation
Abstract
Placental tissue holds great promise as a source of cells for regenerative medicine due to its plasticity, and easy availability. Human placenta-derived mesenchymal stem cells (hPDMSCs) have the potential to differentiate into insulin-producing cells. Upon transplantation, they can reverse experimental diabetes in mice. However, it is not known whether culture-expanded undifferentiated hPDMSCs are capable of restoring normoglycemia upon transplantation in streptozotocin (STZ)-induced diabetic mice. Hence we prepared long-term cultures of hPDMSCs from the chorionic villi of full-term human placenta. Flow cytometry analyses and immunocytochemistry study revealed bonafide mesenchymal nature of the isolated hPDMSCs. These cultures could differentiate into adipogenic, oesteogenic, chondrogenic, and neuronal lineages on exposure to lineage-specific cocktails. Furthermore, we showed that hPDMSCs can form islet-like cell clusters (ILCs) on stepwise exposure to serum-free defined media containing specific growth factors and differentiating agents. qRT-PCR showed the expression of insulin, glucagon, and somatostatin in undifferentiated hPDMSCs and in ILCs. Differentiated ILCs were found to express human insulin, glucagon, and somatostatin by immunocytochemistry. Additionally, ILCs also showed abundance of pancreatic transcription factors ngn3 and isl1. Both undifferentiated hPDMSCs and ILCs exihibited insulin secretion in response to glucose. Transplantation of hPDMSCs or ILCs derived from hPDMSCs in STZ-induced diabetic mice led to restoration of normoglycemia. Our results demonstrate, for the first time, reversal of hyperglycemia by undifferentiated hPDMSCs and ILCs derived from hPDMSCs. These results suggest human placenta-derived MSCs as an alternative source for cell replacement therapy in diabetes.
Fulltext:
HTML
, PDF
(655KB)
This article has been cited by other articles:
|
Influence of nuclear blebs and micronuclei status on the growth kinetics of human mesenchymal stem cells
Sharma S, Bhonde R
J Cell Physiol 2015. 230(3):657-666
|
|
|
Generation of insulin-producing cells from C3H10T1/2 mesenchymal progenitor cells
Jian RL, Mao LB, Xu Y, Li XF, Wang FP, Luo XG, Zhou H, He HP, Wang N, Zhang TC
Gene 2015. 562(1):107-116
|
|
|
Generation of islet-like cell aggregates from human non-pancreatic cancer cell lines
Kanafi MM, Mamidi MK, Sureshbabu SK, Shahani P, Bhawna C, Warrier SR, Bhonde R
Biotechnol Lett 2015. 37(1):227-233
|
|
|
Intravenous Transplantation of Very Small Embryonic Like Stem Cells in Treatment of Diabetes Mellitus
Morteaz A, Iraj RK, Parichehr P, Nader A
Avicenna J Med Biotechnol 2015. 7(1):22-31
|
|
|
Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus
Hashemian SJ, Kouhnavard M, Esfahani EN
J Diabetes Res 2015. In press
|
|
|
Transplantation of placenta-derived mesenchymal stem cell-induced neural stem cells to treat spinal cord injury
Li Z, Zhao W, Liu W, Zhou Y, Jia J, Yang L
Neural Regen Res 2014. 9(24):2197-2204
|
|
|
Proliferative abilities of placenta-derived mesenchymal stem cells at different passages
Bai JP, Li XY, Li X, Yang QW, Liu YN, Wang YM
Chin J Tissue Engin Res 2014. 18(10):1591-1596
|
|
|
Design of bioartificial pancreas with functional micro/nano-based encapsulation of islets
Kepsutlu B, Nazli C, Bal T, Kizilel S
Curr Pharm Biotechnol 2014. 15(7):590-608
|
|
|
Human umbilical cord-derived mesenchymal stem cells can secrete insulin in vitro and in vivo
Boroujeni ZN, Aleyasin A
Biotechnol Appl Biochem 2014. 61(2):82-92
|
|
|
In vitro reconstitution of pancreatic islets
Kojima N
Organogenesis 2014. 10(2):225-230
|
|
|
Improved differentiation of umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells by PDX-1 mRNA transfection
Van Pham P, Thi-My Nguyen P, Thai-Quynh Nguyen A, Minh Pham V, Nguyen-Tu Bui A, Thi-Tung Dang L, Gia Nguyen K, Kim Phan N
Differentiation 2014. 87(5):200-208
|
|
|
miR-375 induces human decidua basalis-derived stromal cells to become insulin-producing cells
Shaer A, Azarpira N, Vahdati A, Karimi MH, Shariati M
Cell Mol Biol Lett 2014. 19(3):483-499
|
|
|
Myocardin and pdx-1 synergistically induce hMSCs to differentiate into insulin secreting cells
Li JT, Sun FX
Biochem Biophys Res Commun 2014. pii: S0006-291X(14)01747-1
|
|
|
Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors
Bhonde RR, Sheshadri P, Sharma S, Kumar A
Int J Biochem Cell Biol 2014. 46:90-102
|
|
|
Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues
Kmiecik G, Spoldi V, Silini A, Parolini O
Stem Cell Rev 2014. In press
|
|
|
Pancreatic tissue resident mesenchymal stromal cell (MSC)-like cells as a source of in vitro islet neogenesis
Gopurappilly R, Bhat V, Bhonde R
J Cell Biochem 2013. 114(10):2240-2247
|
|
|
Transplantation of islet-like cell clusters derived from human dental pulp stem cells restores normoglycemia in diabetic mice
Kanafi MM, Rajeshwari YB, Gupta S, Dadheech N, Nair PD, Gupta PK, Bhonde RR
Cytotherapy 2013. 15(10):1228-1236
|
|
|
Identification of marker molecules for negative screening of pancreatic stem cells
Feng RC, Lang YH, Liang Y, Wu Y, Teng CB
Chin J Tissue Engin Res 2013. 17(10):1785-1792
|
|
|
Placental mesenchymal stem cells: a unique source for cellular cardiomyoplasty
Makhoul G, Chiu RC, Cecere R
Ann Thorac Surg 2013. 95(5):1827-1833
|
|
|
Amniotic stem cell transplantation therapy for type 1 diabetes: a case report
Liu Y, Cao DL, Guo LB, Guo SN, Xu JK, Zhuang HF
J Int Med Res 2013. 41(4):1370-1377
|
|
|
Insulin producing cells established using non-integrated lentiviral vector harboring PDX1 gene
Boroujeni ZN, Aleyasin A
World J Stem Cells 2013. 5(4):217-228
|
|
|
Recent developments in therapies with stem cells from amniotic fluid and placenta
Loukogeorgakis SP, Maghsoudlou P, De Coppi P
Fetal Maternal Med Rev 2013. 24(3):148-168
|
|
|
Review: Public perspectives on the utilization of human placentas in scientific research and medicine
Yoshizawa RS
Placenta 2013. 34(1):9-13
|
|
|
Mesenchymal stem cells: a revolution in therapeutic strategies of age-related diseases
Peng Y, Huang S, Cheng B, Nie X, Enhe J, Feng C, Fu X
Ageing Res Rev 2013. 12(1):103-115
|
|
|
Comparison of cell proliferation, apoptosis, cellular morphology and ultrastructure between human umbilical cord and placenta-derived mesenchymal stem cells
Zhu SF, Zhong ZN, Fu XF, Peng DX, Lu GH, Li WH, Xu HY, Hu HB, He JM, Su WY, He YL
Neurosci Lett 2013. 541:77-82
|
|
|
Placenta as a reservoir of stem cells: an underutilized resource?
Pipino C, Shangaris P, Resca E, Zia S, Deprest J, Sebire NJ, David AL, Guillot PV, De Coppi P
Br Med Bull 2013. 105:43-68
|
|
|
Transduction of mesenchymal stem cells with multidrug resistance gene provides protection for bone marrow toxicity after being transplanted into a nude mice model
Han LY, Li YP, Ye MZ, Wang BW, Wang Q, Zhao SH, Li HL
Chin Med J (Engl) 2012. 125(18):3246-3250
|
|
|
Effect of uric acid on proliferation of human placenta-derived mesenchymal stem cells
Cui J, Yang NL, Wang JY
Chin J Tissue Engin Res 2012. 16(10):1795-1798
|
|
|
Can multiple intramuscular injections of mesenchymal stromal cells overcome insulin resistance offering an alternative mode of cell therapy for type 2 diabetes?
Gopurappilly R, Bhonde R
Med Hypotheses 2012. 78(3):393-395
|
|
|
Abundant expression and hemimethylation of C19MC in cell cultures from placenta-derived stromal cells
Flor I, Neumann A, Freter C, Helmke BM, Langenbuch M, Rippe V, Bullerdiek J
Biochem Biophys Res Commun 2012. 422(3):411-416
|
|
|
Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model
Chen Q, Cheng P, Song N, Yin T, He H, Yang L, Chen X, Wei Y
Oncol Lett 2012. 4(3):413-418
|
|
|
Human term placental cells: phenotype, properties and new avenues in regenerative medicine
Caruso M, Evangelista M, Parolini O
Int J Mol Cell Med 2012. 1(2):64-74
|
|
|
Concise review: mesenchymal stem cells for diabetes
Dominguez-Bendala J, Lanzoni G, Inverardi L, Ricordi C
Stem Cells Trans Med 2012. 1(1):59-63
|
|
|
Stem cells as a tool to improve outcomes of islet transplantation
Sims E, Evans-Molina C
J Transplant 2012. 2012:736491
|
|
|
Long-term cultured human term placenta-derived mesenchymal stem cells of maternal origin displays plasticity
Sabapathy V, Ravi S, Srivastava V, Srivastava A, Kumar S
Stem Cells Int 2012. 2012:174328
|
|
|
Stem cells in stroke repair: current success and future prospects
Gopurappilly R, Pal R, Mamidi MK, Dey S, Bhonde R, Das AK
CNS Neurol Disord Drug Targets 2011. 10(6):741-756
|
|
|
Utility of co-transplanting mesenchymal stem cells in islet transplantation
Sakata N, Goto M, Yoshimatsu G, Egawa S, Unno M
World J Gastroenterol 2011. 17(47):5150-5155
|
|
|
Improving the efficacy of type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells
Ngoc PK, Phuc PV, Nhung TH, Thuy DT, Nguyet NT
Hum Cell 2011. 24(2):86-95
|
|
|
Human umbilical cord blood-derived mesenchymal stem cells improve glucose homeostasis in rats with liver cirrhosis
Jung KH, Uhm YK, Lim YJ, Yim SV
Int J Oncol 2011. 39(1):137-143
|
|
|